Pediatrix Medical Group, Inc.
General ticker "MD" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.3B (TTM average)
Pediatrix Medical Group, Inc. follows the US Stock Market performance with the rate: 51.9%.
Estimated limits based on current volatility of 1.8%: low 21.93$, high 22.71$
Factors to consider:
- Total employees count: 2150 as of 2024
- Top business risk factors: Reimbursement rate changes, Economic downturns and volatility, Market volatility, Management turnover, Strategic risks and growth management
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.65$, 19.48$]
- 2025-12-31 to 2026-12-31 estimated range: [12.04$, 20.00$]
Financial Metrics affecting the MD estimates:
- Positive: with PPE of 9.2 at the end of fiscal year the price was low
- Positive: -5.02 < Operating profit margin, % of -3.30
- Positive: Operating cash flow per share per price, % of 18.11 > 12.91
- Positive: 19.35 < Shareholder equity ratio, % of 35.53 <= 42.53
- Negative: negative Net income
- Positive: -4.41 < Investing cash flow per share per price, % of -3.10
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term MD quotes
Long-term MD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,972.02MM | $1,994.64MM | $2,012.92MM |
| Operating Expenses | $1,799.33MM | $1,987.32MM | $2,081.63MM |
| Operating Income | $172.69MM | $7.32MM | $-68.71MM |
| Non-Operating Income | $-91.32MM | $-55.68MM | $-32.63MM |
| Interest Expense | $39.70MM | $42.08MM | $40.74MM |
| Income(Loss) | $81.37MM | $-48.36MM | $-101.34MM |
| Taxes | $18.81MM | $12.05MM | $-2.27MM |
| Other Income(Loss) | $3.77MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $66.33MM | $-60.41MM | $-99.07MM |
| Stockholders Equity | $891.63MM | $849.06MM | $764.94MM |
| Assets | $2,347.89MM | $2,219.81MM | $2,152.70MM |
| Operating Cash Flow | $166.94MM | $137.32MM | $206.57MM |
| Capital expenditure | $29.71MM | $33.33MM | $22.02MM |
| Investing Cash Flow | $-56.95MM | $-48.18MM | $-35.41MM |
| Financing Cash Flow | $-487.55MM | $-25.71MM | $-14.48MM |
| Earnings Per Share** | $0.80 | $-0.72 | $-1.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.